GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Regenerative Medicine International Ltd (HKSE:08158) » Definitions » 3-Year Dividend Growth Rate

China Regenerative Medicine International (HKSE:08158) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is China Regenerative Medicine International 3-Year Dividend Growth Rate?

China Regenerative Medicine International's Dividends per Share for the three months ended in Jun. 2024 was HK$0.00.

The historical rank and industry rank for China Regenerative Medicine International's 3-Year Dividend Growth Rate or its related term are showing as below:

HKSE:08158's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 13.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

China Regenerative Medicine International's Dividend Payout Ratio for the three months ended in Jun. 2024 was 0.00. As of today, China Regenerative Medicine International's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of China Regenerative Medicine International's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, China Regenerative Medicine International's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Regenerative Medicine International's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where China Regenerative Medicine International's 3-Year Dividend Growth Rate falls into.



China Regenerative Medicine International 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


China Regenerative Medicine International  (HKSE:08158) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

China Regenerative Medicine International's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ 0
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Regenerative Medicine International 3-Year Dividend Growth Rate Related Terms>


China Regenerative Medicine International Business Description

Traded in Other Exchanges
N/A
Address
132 Nathan Road, Suite 2310–18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.
Executives
Wang Chuang 2101 Beneficial owner
Wong Kwok Keung 2501 Other
Arab Osman Mohammed 2501 Other
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Lei Changjuan 2101 Beneficial owner
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Kong Yudong 2101 Beneficial owner
Li Ren 2201 Interest of corporation controlled by you
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited) 2201 Interest of corporation controlled by you
All Favour Holdings Limited 2101 Beneficial owner
Deng Shufen 2202 Interest of your spouse
Dai Yumin 2201 Interest of corporation controlled by you
Wang Xiaogang 2101 Beneficial owner
China Orient Asset Management Co., Ltd. 2106 Person having a security interest in shares
China Orient Alternative Investment Fund 2106 Person having a security interest in shares

China Regenerative Medicine International Headlines

No Headlines